Have you or someone you know taken Zantac® and subsequently been diagnosed with cancer?

Officials at the Food and Drug Administration (FDA) have ordered all ranitidine medications, sold under the brand name Zantac®, taken off store shelves immediately. The order is tied to concerns that the medication may contain a cancer-causing chemical. Based upon recent testing by a respected independent laboratory and a resulting petition filed with the FDA, there are claims that Zantac® (and the generic ranitidine) causes high levels of the carcinogen Nitrosodimethylamine (NDMA) exposure in patients. Studies have linked the hepatotoxin NDMA to cancer in both animals and humans.